We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

1 hedge funds and large institutions have $76K invested in Dicerna Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $73K | Put options by funds: $20K

99% less funds holding

Funds holding: 173 → 1 (-172)

100% less capital invested

Capital invested by funds: $1.25B → $76K (-$1.25B)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 170

Holders
1
Holders Change
-172
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
170
Calls
$73K
Puts
$20K
Net Calls
+$53K
Net Calls Change
-$10.6M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$153M
2
BlackRock
BlackRock
New York
-$116M
3
State Street
State Street
Massachusetts
-$78.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$74.7M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$62.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
151
CAPTRUST Financial Advisors
North Carolina
– -$11K -563 Closed
NFG
152
Next Financial Group
Texas
– -$10K -500 Closed
HWA
153
HHM Wealth Advisors
Tennessee
– -$10K -483 Closed
SIC
154
Salem Investment Counselors
North Carolina
– -$8K -375 Closed
CTC
155
Central Trust Company
Missouri
– -$6K -300 Closed
Rockefeller Capital Management
156
Rockefeller Capital Management
New York
– -$5K -280 Closed
QT
157
Quantbot Technologies
New York
– -$5K -272 Closed
Daiwa Securities Group
158
Daiwa Securities Group
Japan
– -$5K -266 Closed
MPWT
159
MassMutual Private Wealth & Trust
Connecticut
– -$4K -215 Closed
PNC Financial Services Group
160
PNC Financial Services Group
Pennsylvania
– -$4K -208 Closed
PA
161
Parallel Advisors
California
– -$4K -200 Closed
AF
162
Advisornet Financial
Minnesota
– -$4K -194 Closed
TC
163
Truvestments Capital
Florida
– -$3K -126 Closed
QCG
164
Quadrant Capital Group
Ohio
– -$2K -119 Closed
S
165
SignatureFD
Georgia
– -$2K -119 Closed
TFGT
166
TS Financial Group (TSFG)
Illinois
– -$2K -100 Closed
FDCDDQ
167
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$1.51K -75 Closed
CWP
168
Concord Wealth Partners
Virginia
– -$1K -59 Closed
EI
169
Ellevest Inc
New York
– -$1K -29 Closed
3 4 5 6
7

DRNA Hedge Fund Activity: Q4 2021 in Review

1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q4 2021, worth a combined $76K — down 100% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 170 funds closed out of DRNA and 0 opened new positions — a net loss of 170 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $153M sold.

  • 1 institutional investor held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q4 2021, down from 173 in Q3 2021.
  • Funds reported $76K of Dicerna Pharmaceuticals, Inc. stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q4 2021 and 170 closed out, a net change of -170 holders.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q4 2021 was RTW Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q4 2021.